MM Group for Industry and International Trade announced that the Board of Directors has agreed to invest a maximum amount of EGP 205 million, in order to acquire 40% of B Pharma, a specialized investment company in the field of drug distribution and trade services in Egypt, in partnership with B Investments Holding Company, and authorizing Khaled Jamal El Din, in his capacity as CEO and Managing Director of the company, signed the subscription and investment agreement.